Blood Screening Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Blood screening is a test, which is used to perform before blood donation to ensure that blood units are safe. Screening for some diseases are should be mandatory such as, HIV, hepatitis B, hepatitis C and syphilis. In addition, regular blood testing helps to prevent and treat conditions associated with hormone imbalances, including weight gain, erectile dysfunction, fatigue, bone loss, memory impairment and depressed mood.

MARKET DYNAMICS

The blood screening market is anticipated to grow in the forecast, owing to rising awareness regarding maintaining of safety of donated blood, increasing prevalence of infectious diseases, increase in health care expenditure, increasing adoption of nucleic acid testing and increasing awareness about health care. In addition, rising number of initiatives by various governments and government associations is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Blood Screening Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of blood screening market with detailed market segmentation by technology, product and service, end user and geography. The global blood screening market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading blood screening market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global blood screening market is segmented on the basis technology, product and end user. Based on technology, the market is segmented as, nucleic acid test (NAT), enzyme-linked immunosorbent assay (ELISA), western blot assay, next-generation sequencing (NGS) and rapid tests. The blood screening market is categorized based on product such as reagents & kits, instruments and software & services. Based on end user, the market is bifurcated into, hospitals and blood banks.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global blood screening market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The blood screening market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting blood screening market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the blood screening market in these regions.

Blood Screening Market Report Analysis

Blood Screening Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• BD
• Beckman Coulter, Inc.
• Thermo Fisher Scientific Inc.
• Siemens
• Bio-Rad Laboratories, Inc.
• Abbott
• F. Hoffmann-La Roche Ltd
• Grifols, S.A.
• bioMérieux SA

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Technology

• Nucleic Acid Test
• Enzyme-Linked Immunosorbent Assay
• Western Blot Assay
• Next-Generation Sequencing
• Rapid Tests

By Product and Service

• Reagents and Kits
• Instruments
• Software and Services

By End User

• Hospitals
• Blood Banks

MARKET PLAYERS

The reports cover key developments in the blood screening market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from blood screening market are anticipated to lucrative growth opportunities in the future with the rising demand for blood screening market in the global market. Below mentioned is the list of few companies engaged in the blood screening market.

The report also includes the profiles of key blood screening market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  BD
•  Beckman Coulter, Inc.
•  Thermo Fisher Scientific Inc.
•  Siemens
•  Bio-Rad Laboratories, Inc.
•  Abbott
•  F. Hoffmann-La Roche Ltd
•  Grifols, S.A.
•  bioMérieux SA
•  Ortho Clinical Diagnostics

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Blood Screening Market Report Scope